Dabigatran etexilate Completed Phase 2 Trials for Venous Thromboembolism (VTE)

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT02223260Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age
NCT01083732Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age